Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cumulative Adverse Childhood Experiences and Multiple Neurodevelopmental Disorders in Children and Adolescents: A Population-Based Study.

Stress and health : journal of the International Society for the Investigation of Stress·2026
Same author

Diagnostic complexities of autism and psychosis: A commentary on the ANZJP GRADE guidelines for the management of schizophrenia.

The Australian and New Zealand journal of psychiatry·2026
Same author

Managing in war, planning for peace: second report of The Lancet Psychiatry Commission on mental health in Ukraine.

The lancet. Psychiatry·2026
Same author

Initial physical health assessment for psychosis in Australia and New Zealand: 2026 recommendations.

The Australian and New Zealand journal of psychiatry·2026
Same author

Estimating burden of disease attributable to child maltreatment using findings from the Australian Child Maltreatment Study.

Epidemiology and psychiatric sciences·2026
Same author

Coping with Climate Change: Correlates of Adaptive and Maladaptive Coping in Young People.

Chronic stress (Thousand Oaks, Calif.)·2026

Related Experiment Videos

The RBANS Effort Index: base rates in geriatric samples.

Kevin Duff1, Cynthia C Spering, Sid E O'Bryant

  • 1Center for Alzheimer's Care, Imaging and Research, Department of Neurology, University of Utah, Salt Lake City, Utah 84108, USA. kevin.duff@hsc.utah.edu

Applied Neuropsychology
|March 11, 2011
PubMed
Summary
This summary is machine-generated.

The Effort Index (EI) may unfairly flag older adults with dementia for poor effort. Age, education, and cognitive status impact EI scores, requiring careful interpretation in geriatric patients.

Related Experiment Videos

Area of Science:

  • Neuropsychology
  • Geriatric Medicine
  • Cognitive Assessment

Background:

  • The RBANS Effort Index (EI) aids in distinguishing genuine cognitive impairment from poor effort.
  • Concerns exist that the EI may disproportionately penalize older adults due to its use of uncorrected raw scores.

Purpose of the Study:

  • To investigate the base rates of Effort Index failure in geriatric populations.
  • To determine if age, education, and cognitive functioning influence Effort Index scores in older adults.

Main Methods:

  • Analysis of five independent samples of geriatric patients with varying cognitive abilities.
  • Calculation of base rates for Effort Index failure across different cognitive strata.
  • Examination of correlations between Effort Index scores and demographic/cognitive variables.

Main Results:

  • In cognitively intact and mildly impaired older adults, few were classified as demonstrating poor effort (approx. 3%).
  • Among severely impaired geriatric patients (nursing home residents, probable Alzheimer's disease), over one-third exceeded EI cutoff scores (33-37%).
  • Older age, lower education, and poorer overall cognitive functioning were associated with higher rates of suspected poor effort on the EI.

Conclusions:

  • The Effort Index's interpretation in older adults requires careful consideration of age, education, and cognitive status.
  • Caution is advised when using the Effort Index with elderly individuals, particularly those suspected of dementia, due to potential confounding factors.